{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:30:31Z","timestamp":1747171831712,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.tvjl.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:16:30Z","timestamp":1431087390000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells"],"prefix":"10.1016","volume":"205","author":[{"given":"Hiroki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-8151","authenticated-orcid":false,"given":"Satoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2015.05.003_bib0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.yexcr.2004.12.014","article-title":"Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription","volume":"305","author":"Endoh","year":"2005","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0015","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1200\/JCO.2008.21.1862","article-title":"Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer","volume":"27","author":"Giaccone","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0020","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1124\/dmd.111.040733","article-title":"Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein","volume":"39","author":"Iwai","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3892\/ijo.2013.1805","article-title":"Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM\/NF-\u03baB pathway in lung cancer cells","volume":"42","author":"Ke","year":"2013","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2460\/javma.239.1.90","article-title":"Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma","volume":"239","author":"Klahn","year":"2011","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0035","first-page":"2013","article-title":"Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase\/protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line","volume":"13","author":"Li","year":"2013","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0040","first-page":"1469","article-title":"Survivin transcription is associated with P-glycoprotein\/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells","volume":"23","author":"Liu","year":"2010","journal-title":"Oncology Reports"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.20656","article-title":"IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes","volume":"81","author":"Nakagawa","year":"2006","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0050","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1158\/0008-5472.CAN-07-1343","article-title":"YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts","volume":"67","author":"Nakahara","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1267\/ahc.06005","article-title":"Survivin as a prognostic factor for osteosarcoma patients","volume":"39","author":"Osaka","year":"2006","journal-title":"Acta Histochemica et Cytochemica"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1939-1676.2010.0588.x","article-title":"Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma","volume":"24","author":"Rassnick","year":"2010","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0065","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.2174\/092986712801661040","article-title":"Survivin as a prognostic\/predictive marker and molecular target in cancer therapy","volume":"19","author":"R\u00f6del","year":"2012","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0070","first-page":"103","article-title":"Survivin: Anti-apoptosis protein and a prognostic marker for tumor progression and recurrence","volume":"141","author":"Sela","year":"2002","journal-title":"Harefuah"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/0008-5472.CAN-11-2315","article-title":"Expression and function of survivin in canine osteosarcoma","volume":"72","author":"Shoeneman","year":"2012","journal-title":"Cancer Research"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0080","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1158\/0008-5472.CAN-07-0494","article-title":"Nuclear and cytoplasmic survivin: Molecular mechanism, prognostic, and therapeutic potential","volume":"67","author":"Stauber","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/annonc\/mdr353","article-title":"A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer","volume":"23","author":"Tolcher","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0090","first-page":"603","article-title":"Disruption of survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571","volume":"6","author":"Wang","year":"2008","journal-title":"Cancer Therapy"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0095","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-10-3410","article-title":"Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models","volume":"17","author":"Yamanaka","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0100","doi-asserted-by":"crossref","first-page":"e79810","DOI":"10.1371\/journal.pone.0079810","article-title":"Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines","volume":"8","author":"Yamazaki","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tvjl.2015.05.003_bib0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jvim.12244","article-title":"Comparative analysis of mRNA expression of surface antigens between histiocytic and non-histiocytic sarcoma in dogs","volume":"28","author":"Yamazaki","year":"2014","journal-title":"Journal of Veterinary Internal Medicine"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T15:54:47Z","timestamp":1566662087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023315001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1090023315001835"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.05.003","relation":{},"ISSN":["1090-0233"],"issn-type":[{"type":"print","value":"1090-0233"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}